substance use disorder

7 · 20 / page

Ask MedXY AI

Latest news

Tag

Diabetes & Endocrinologyhospitalisation ratesdiabetes

GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study

By MedXY|Aug 10, 2026

This Swedish register-based study reveals that GLP-1 receptor agonists are associated with significantly reduced hospitalisations for alcohol and substance use disorders during treatment, with some lasting benefits after discontinuation of

Spirituality as a Protective Factor Against Substance Use Disorders: Evidence from a 21st-Century Meta-Analysis

newspsychiatry

substance use disorder

Latest news

GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study

Spirituality as a Protective Factor Against Substance Use Disorders: Evidence from a 21st-Century Meta-Analysis

Psychosocial Interventions for Dual-Diagnosis Schizophrenia: A Critical Appraisal of Efficacy and the Urgent Need for Innovation

Stopping Smoking Is Associated With Better Recovery From Other Substance Use Disorders: Longitudinal Evidence From a US National Cohort

Telehealth Prescribing of ADHD Stimulants: Assessing Risks for Subsequent Substance Use Disorders

Heart Rate Variability Biofeedback in Substance Use Disorder: Emerging Evidence from a Randomized Clinical Trial and Contextual Review

E-cigarettes versus Combination Nicotine Replacement Therapy for Smoking Cessation in Substance Use Disorder Patients: Integrative Analysis of Recent Trials and Longitudinal Patterns